Skip to main content
. 2018 Apr 13;9:1461. doi: 10.1038/s41467-018-03687-x

Fig. 6.

Fig. 6

Crossreactive antibodies inhibit ELR+ CXC chemokine signaling in vitro. Residual activity of a human hCXCL1, hCXCL5, and hCXCL8 and b mouse mCXCL1 and mCXCL2 chemokines incubated with varying concentrations of SA129 (red), SA138 (blue), and SA157* (gray) fusions, and commercial neutralizing antibodies (Ab, white). The indicated values are the means of three independent experiments. c Plot displaying pKi versus the calculated pKD of SA129 (red), SA138 (blue), and SA157* (gray) fusions. Data are presented as mean (dots) ± s.e.m. (bars)